Danofloxacin Mesylate

Danofloxacin Mesylate

Catalog Number:
M001341947TOK
Mfr. No.:
TOK-D090
Price:
$176
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Danofloxacin Mesylate is a synthetic, broad-spectrum fluoroquinolone with antibacterial activity. It is used in veterinary medical research applications. It is used to combat the organisms causing respiratory disease in cattle, chickens, and pigs.

          Please contact us at for specific academic pricing.

          Background

          Fluoroquinolone antibiotics target bacterial DNA gyrase (topoisomerase type II), an enzyme which reduces DNA strain during replication and is essential for DNA packaging, transcription, and replication. Thus, DNA synthesis and cell division is inhibited.

      • Properties
        • CAS Number
          119478-55-6
          Molecular Formula
          C19H20FN3O3 • CH4O3S
          Molecular Weight
          453.49
          Appearance
          White to light yellow powder
          Solubility
          Soluble in DMSO and methanol
          Other Properties
          Source: Synthetic
          Storage
          2-8 °C

          * For research use only

      • Applications
        • Application Description
          Spectrum: Broad-spectrum, including Gram-positive and Gram-negative bacteria. Also effective for Mycoplasmas. Representative genera include Actinobacillus, Escherichia, Klebsiella, Mannheima, Salmonella, and Staphylococcus.

          Microbiology Applications: Danofloxacin is effective for cattle pathogens such as Pasteurella multocida, Mannheimia haemolytica, and Histophilus somni. Danofloxacin is highly active in vitro against Mycoplasma species that cause respiratory infections in cattle, pigs, and poultry (Cooper et al, 1993). Representative MIC values include: o Mycoplasma species 0.008 µg/mL – 0.5 µg/mL o Pasteurella mulltocida 0.00375-0.125 ug/ml o

          Eukaryotic Cell Culture Applications: The potential effect of Danofloxacin on oxidative stress was examined in vitro. Danofloxacin did not induce oxidative stress in LLC-PK1 cells during exposure of ≤400 μM for 24 hours. Assessment involved reviewing reactive oxygen species (ROS) level, lipid peroxidation, cell apoptosis and antioxidative enzyme activities. Authors note noted an increased activity of antioxidant enzymes (superoxide dismutase and catalase). (Yue et al, 2013).

    Note: If you don't receive our verification email, do the following:

  • Copyright © Amerigo Scientific. All rights reserved.